Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,275 | 2,616 | 51,943 | 42,858 | 27,427 |
| Depreciation Amortization | 2,187 | 1,105 | 3,969 | 2,920 | 1,921 |
| Income taxes - deferred | 1,537 | -123 | 17,289 | 12,141 | 8,368 |
| Accounts receivable | -15,582 | 395 | -11,627 | -29,407 | -11,036 |
| Accounts payable and accrued liabilities | 6,285 | -2,628 | -8,460 | -5,814 | -2,568 |
| Other Working Capital | -16,180 | -4,009 | -29,569 | -38,170 | -21,342 |
| Other Operating Activity | 27,066 | 7,565 | 35,374 | 48,470 | 22,342 |
| Operating Cash Flow | $10,588 | $4,921 | $58,919 | $32,998 | $25,112 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -19 | -4,436 | -1,706 | -884 |
| Purchase Sale Intangibles | N/A | N/A | -750 | -750 | N/A |
| Other Investing Activity | 0 | 0 | -750 | -750 | 0 |
| Investing Cash Flow | $-19 | $-19 | $-5,186 | $-2,456 | $-884 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 50,000 | 50,000 | N/A |
| Debt Repayment | -1,250 | N/A | -1,250 | N/A | N/A |
| Common Stock Issued | 6,668 | 1,166 | 4,338 | 4,165 | 4,130 |
| Common Stock Repurchased | -10,519 | -7,003 | -43,792 | -38,790 | -25,311 |
| Other Financing Activity | -19,878 | -18,052 | -1,192 | -1,192 | -482 |
| Financing Cash Flow | $-24,979 | $-23,889 | $8,104 | $14,183 | $-21,663 |
| Beginning Cash Position | 114,657 | 114,657 | 52,820 | 52,820 | 52,820 |
| End Cash Position | 100,247 | 95,670 | 114,657 | 97,545 | 55,385 |
| Net Cash Flow | $-14,410 | $-18,987 | $61,837 | $44,725 | $2,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,588 | 4,921 | 58,919 | 32,998 | 25,112 |
| Capital Expenditure | -19 | -19 | -4,436 | -1,706 | -884 |
| Free Cash Flow | 10,569 | 4,902 | 54,483 | 31,292 | 24,228 |